e8vk
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): June 16, 2009 (May 21, 2009)
Vermillion, Inc.
(Exact name of registrant as specified in its charter)
Commission File Number: 000-31617
|
|
|
Delaware
|
|
33-059-5156 |
(State or other jurisdiction
of incorporation)
|
|
(IRS Employer
Identification No.) |
47350 Fremont Blvd., Fremont, CA 94538
(Address of principal executive offices, including zip code)
510.226.2800
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 8.01. Other Events.
FDA Response
Vermillion, Inc. (the Company) currently has a 510(k) pre-market notification pending before the
FDA. In Feb 2009, and in March 2009, the FDA asked Vermillion for additional information regarding
the submission. Following a number of constructive substantive discussions between Vermillion and
the FDA, on June 11, 2009, Vermillion submitted information to the FDA that it believes responds to
all questions raised by the FDA to date.
This statement regarding Vermillions response to the FDA may contain forward-looking statements
that involve significant risks and uncertainties, including statements regarding Vermillions
plans, objectives, expectations and intentions and risks and uncertainties. Such risks are
discussed in Vermillions latest Form 10-K and Vermillions periodic reports on Form 10-Q and Form
8-K. These forward-looking statements are based on Vermillions current expectations. Vermillion
is providing this information as of the date of the filing of this Current Report on Form 8-K and
does not undertake any obligation to update any forward-looking statements as a result of new
information, future events or otherwise. Forward-looking statements cannot be guaranteed and actual
results may differ materially from Vermillions current expectations.
Monthly Operating Reports
On May 21, 2009, Vermillion, Inc. (the Company) filed its financial statements included in the
Monthly Operating Report for the period from March 30, 2009 to April 30, 2009 (the Monthly
Operating Report) with the United States Bankruptcy Court for the District of Delaware (the
Bankruptcy Court) (Case No. 09-11091). A copy of the Monthly Operating Report is attached to
this Current Report on Form 8-K as Exhibit 99.1 and incorporated in this report by reference.
Under the Exchange Act, the SEC issued Exchange Act release 9660 providing guidance for Exchange
Act reporting companies in bankruptcy. Consistent with that release, in light of limitations on
the Companys liquidity and personnel, the Company is unable to continue filing periodic reports
under the Exchange Act without unreasonable effort and expense because (i) the Companys regular
accounting staff has been reduced as a result of the bankruptcy filing and (ii) the cost of having
an independent registered public accounting firm perform the requisite reviews and audits coupled
with the cost of complying with the requirements of the Sarbanes-Oxley Act of 2002 is prohibitive.
As a result, the Company hereafter intends to file with the SEC, under cover of current reports on
Form 8-K, in lieu of filing Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, copies
of the Companys monthly operating reports required to be submitted to the Bankruptcy Court. In
accordance with General Instructions B.2 and B.6 of Form 8-K, the Monthly Reports are, and any
future such monthly operating reports will be, furnished for informational purposes only and shall
not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that section, nor will such information be
deemed incorporated by reference in any filing under the Exchange Act or the Securities Act,
except as expressly set forth by specific reference in such a filing. The information set forth in
this Item 9 also will not be deemed an admission as to the materiality of any information required
to be disclosed solely to satisfy the requirements of Regulation FD.
The Company cautions investors and potential investors not to place undue reliance upon the
information contained in the Monthly Operating Report, which was not prepared for the purpose of
providing the basis for an investment decision relating to any of the securities of the Company.
The Monthly Operating Report is limited in scope, covers a limited time period and has been
prepared solely for the purpose of the Companys compliance with the monthly reporting requirements
of the Bankruptcy Court. The financial information in the Monthly Operating Report was not audited
or reviewed by independent registered accountants and is not presented in accordance with U.S.
Generally Accepted Accounting Principles (GAAP) and is in a format prescribed by applicable
bankruptcy laws and is subject to future adjustment and reconciliation. There can be no assurance
that, from the perspective of an investor or potential investor in the Companys securities, the
Monthly Operating Report is complete. The Monthly Operating Report also contains information for
periods which may be shorter or otherwise different from those contained in reports required
pursuant to the Securities Exchange Act of 1934, as amended (the Exchange Act), and such
information is likely not indicative of Companys financial condition or operating results for the
period that
would be reflected in the periodic reports pursuant to the Exchange Act. The Monthly Operating
Report does not include footnotes that would ordinarily be contained in the financial statements in
our quarterly and annual reports pursuant to the Exchange Act. In addition, the income tax
provision in the Monthly Operating Reports is difficult to ascertain as a result of many factors,
including, among other things, our inability to predict taxable income that may be generated as a
result of any cancellation of indebtedness that might occur as a result of the bankruptcy
proceeding involving the Company. Results set forth in the Monthly Operating Reports should not be
viewed as indicative of future results.
Bankruptcy Materials
On June 11, 2009, the Company filed a Statement of Financial Affairs and Schedules of Assets and
Liabilities, which included Global Notes and Statement of Limitations, Methodology and Disclaimer
Regarding Debtors Statements of Financial Affairs with Schedules (the Global Notes), a Statement
of Financial Affairs (the Statement) and certain Schedules of Assets and Liabilities (the
Schedules and with the Global Notes and Statement, the Bankruptcy Materials) with the
Bankruptcy Court. The Bankruptcy Materials contain unaudited summary financial information
relating to the Debtors assets and liabilities in the form required under the Bankruptcy Code and
the rules and regulations thereunder. A copy of the Bankruptcy Reports is attached to this Current
Report on Form 8-K as Exhibit 99.2 and incorporated in this report by reference.
The Company cautions investors and potential investors not to place undue reliance upon the
information contained in the Bankruptcy Materials, which were not prepared for the purpose of
providing the basis for an investment decision relating to any of the securities of the Company.
The Bankruptcy Materials contain financial information that has not been audited or reviewed by
independent registered accountants and is not presented in accordance with U.S. GAAP. The
information contained in the Bankruptcy Materials has been prepared in accordance with the
Bankruptcy Code and the rules and regulations thereunder and was not prepared for the purpose of
providing a basis for an investment decision relating to any securities of the Company. The
Bankruptcy Materials also contain information for periods that are shorter or otherwise different
from those required by the periodic reporting requirements of the Exchange Act, and the rules and
regulations thereunder, and such information may not be indicative of the Companys financial
condition or operating results for the period that would be reflected in its financial statements
or in its reports pursuant to the Exchange Act or the rules and regulations thereunder. Results
set forth in the Bankruptcy Materials should not be viewed as indicative of future results. There
can be no assurance that the Bankruptcy Materials are complete. The Company may amend, supplement
or otherwise change the information contained in the Bankruptcy Materials at a future date.
Cash Budget Through December, 2009
On June 16, 2009 the Board of Directors of the Company approved the Companys Cash Budget through
December, 2009 (the Cash Budget). A copy of the Cash Budget is attached to this Current Report
on Form 8-K as Exhibit 99.3 and incorporated in this report by reference.
The Company cautions investors and potential investors not to place undue reliance upon the
information contained in the Cash Budget, which was not prepared for the purpose of providing the
basis for an investment decision relating to any of the securities of the Company. The Cash Budget
contains financial information that has not been audited or reviewed by independent registered
accountants and is not presented in accordance with U.S. GAAP. The information contained in the
Cash Budget was not prepared for the purpose of providing a basis for an investment decision
relating to any securities of the Company. The Cash Budget also contains information for periods
that are shorter or otherwise different from those required by the periodic reporting requirements
of the Exchange Act, and the rules and regulations thereunder, and such information may not be
indicative of the Companys financial condition or operating results for the period that would be
reflected in its financial statements or in its reports pursuant to the Exchange Act or the rules
and regulations thereunder. Results set forth in the Cash Budget should not be viewed as
indicative of future results. There can be no assurance that the Cash Budget is complete. The
Company may amend, supplement or otherwise change the information contained in the Cash Budget at a
future date.
Forward-Looking Statements
Certain matters discussed in this Current Report on Form 8-K and the exhibits hereto contain
forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Exchange Act. These forward-looking statements may relate to,
among other things, expectations of the business environment in which the Company operates,
projections of future performance and projections of future expenses. These forward-looking
statements are based upon current management expectations and may therefore involve risks and
uncertainties. Certain of these forward-looking statements are only estimates of the anticipated
cash and expenses of the Company, and of the operating requirements of the Company through
December, 2009. The Companys actual expenses may be affected by a wide range of factors,
including, but not limited to: anticipated expenses may significantly increase; unanticipated or
unforeseen expenses may arise; changes to FDA regulations, and any delay by or failure of the FDA
to approve any of Vermillions diagnostic tests submitted to the FDA, may result in unanticipated
expenses; the overall financial situation and needs of the Company or its research could change;
and unanticipated litigation could arise and could result in increased expenses. The Companys
Chapter 11 filing may disrupt and distract management. Moreover, the Chapter 11 filing could
result in unanticipated expenses or increases to estimated expenses, including respecting possible
financing, sale of assets and/or a plan of reorganization, any one or all of which could be
substantial. The Companys actual results or performance may differ materially from those
suggested, expressed, or implied by forward-looking statements due to a wide range of factors, and
although the Company believes that its expectations and beliefs are based on reasonable
assumptions, it can give no assurance that its goals will be achieved. The Company disclaims any
obligation to subsequently revise or update any forward-looking statements to reflect events or
circumstances after the date of such statements or to reflect the occurrence of anticipated or
unanticipated events.
Item 9.01. Financial Statements and Exhibits.
|
|
|
|
|
|
|
(d) |
|
Exhibit No. |
|
|
Description. |
|
|
|
|
|
|
|
|
|
|
99.1 |
|
|
Monthly Operating Report for the Period March 30, 2009 April 30, 2009. |
|
|
|
|
|
|
|
|
|
99.2 |
|
|
Statement of Financial Affairs and Schedules of Assets and Liabilities. |
|
|
|
|
|
|
|
|
|
99.3 |
|
|
Cash Budget for Vermillion, Inc. through December, 2009. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
Vermillion, Inc.
|
|
Date: June 16, 2009 |
By: |
/s/ Gail S. Page
|
|
|
|
Gail S. Page |
|
|
|
Executive Chair of the Board of
Directors |
|
EXHIBIT INDEX
|
|
|
Exhibit No. |
|
Description |
|
|
|
99.1
|
|
Monthly Operating Report for the Period March 30, 2009 April 30, 2009. |
|
|
|
99.2
|
|
Statement of Financial Affairs and Schedules of Assets and Liabilities. |
|
|
|
99.3
|
|
Cash Budget for Vermillion, Inc. through December, 2009. |